NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Expedition Medicines

Expedition Medicines

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://expeditionmedicines.com/

Last Round

Seed

Oct 22, 2025

Total Funding Raised

$50M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Expedition Medicines is a biotechnology company that is building an AI platform to generate small molecule drugs against disease-driving proteins that have long been considered undruggable.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoverybiotechnologygenerative chemistrybio-discovery platformai drug discoverysmall molecule discoverychemoproteomicsundruggable targetsquantum chemistrytherapeutic pipelinein silico drug designbioactive compoundsai biotechpre-clinical researchdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Expedition Medicines Comps

Public and private peers based on sector, stage, and business model.

Expedition Medicines comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Expedition Medicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 22, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Henry van den Bedem

CTO

Executive Team

Expedition Medicines Investors

Notable investors and investment history

Expedition Medicines investors
InvestorRounds
Flagship PioneeringSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 82% MoM.

  • Oct 22, 2025

    $50M Series A round completed.

View all signals

Expedition Medicines Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Expedition Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Expedition Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range49
Year Founded2022
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.